New York Times  |  May 4, 2023

The country has undergone a “decided shift” in favor of harm reduction, said Regina LaBelle, who led the White House’s Office of National Drug Control Policy under President Biden. In 2015, Congress lifted a funding ban for needle exchanges, where clean syringes are distributed to keep people from reusing or sharing potentially infected devices. And in March, the F.D.A. for the first time made naloxone, a medication that reverses opioid overdoses, available over the counter.

Read more here.